United States set
language
Menu Shopping cart $0 Search
Advanced Search
You are here:   Home Products by Molecule of Interest miR-361-5p

References to miR-361-5p

  • Han, Jianjun, et al. "Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway." Bosnian Journal of Basic Medical Sciences 19.1 (2019): 52.
  • Kanitz, Alexander, et al. "The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma." PLoS One 7.11 (2012): e49568.
  • Liu, Dachuang, et al. "MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6 (STAT6)." Biochemical and biophysical research communications 445.1 (2014): 151-156.
  • Ma, Fei, et al. "MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1." Oncotarget 6.19 (2015): 17404.
  • Sun, Jian-Jun, Guo-Yong Chen, and Zhan-Tao Xie. "MicroRNA-361-5p inhibits cancer cell growth by targeting CXCR6 in hepatocellular carcinoma." Cellular Physiology and Biochemistry38.2 (2016): 777-785.
  • Zhang, Xi, et al. "MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1." Oncology reports 37.3 (2017): 1849-1856.
  • Hou, X. W., et al. "miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1." Neoplasma 64.4 (2017): 526-534.
  • Ma, Fei, et al. "MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1." Journal of Experimental & Clinical Cancer Research 36.1 (2017): 158.
  • Han, Jianjun, et al. "Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway." Bosnian Journal of Basic Medical Sciences 19.1 (2019): 52.
  • Wu, Xiaomei, et al. "MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition." Medical Oncology 30.4 (2013): 751.
  • Chen, Yao-ping, et al. "The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism." Scientific reports 6 (2016): 23531.
  • Wang, Feng, et al. "Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction." PLoS One 9.9 (2014): e105734.